Crispr Therapeutics shares owned by Stonepine Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stonepine Capital Management
from 13F filings
Historical chart of Stonepine Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Stonepine Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.6M | 50k | 52.44 |
More positions owned by Stonepine Capital Management
View all positions for Stonepine Capital Management